Barclays’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q1 | – | Sell |
-2,085,179
| Closed | -$33.4M | – | 4337 |
|
|
2014
Q4 | $33.4M | Buy |
2,085,179
+967,306
| +87% | +$15.5M | 0.03% | 276 |
|
|
2014
Q3 | $12.3M | Buy |
1,117,873
+437,288
| +64% | +$4.81M | 0.01% | 567 |
|
|
2014
Q2 | $3.4M | Sell |
680,585
-31,351
| -4% | -$157K | ﹤0.01% | 1127 |
|
|
2014
Q1 | $2.14M | Buy |
711,936
+241,309
| +51% | +$724K | ﹤0.01% | 1297 |
|
|
2013
Q4 | $1.41M | Buy |
470,627
+408,767
| +661% | +$1.23M | ﹤0.01% | 1572 |
|
|
2013
Q3 | $248K | Sell |
61,860
-547,428
| -90% | -$2.19M | ﹤0.01% | 2506 |
|
|
2013
Q2 | $2.8M | Buy |
+609,288
| New | +$2.8M | ﹤0.01% | 1118 |
|